Valuation: Renalytix Plc

Market Cap 13.34M 11.73M 10.9M 10.01M 18.79M 1.29B 19.11M 130M 50.58M 631M 50.06M 48.98M 2.18B P/E 2024
-0.45x
P/E 2025 -1.34x
Enterprise Value 17.94M 15.78M 14.67M 13.47M 25.28M 1.73B 25.7M 174M 68.02M 849M 67.33M 65.88M 2.94B EV / Sales 2024
11,059,330x
EV / Sales 2025 12,499,418x
Free-Float
73.31%
Yield 2024 *
-
Yield 2025 -
1 week-3.64%
Current month+15.22%
1 month+39.47%
3 months+43.24%
6 months-57.60%
Current year-55.08%
1 week 2.5
Extreme 2.5
3
1 month 1.8
Extreme 1.8
3
Current year 1.6
Extreme 1.6
6.5
1 year 1.6
Extreme 1.6
15.5
3 years 1.6
Extreme 1.6
125
5 years 1.6
Extreme 1.6
1,190
10 years 1.6
Extreme 1.6
1,220
Manager TitleAgeSince
Chief Executive Officer 58 15/03/2018
Director of Finance/CFO 68 28/05/2024
President 65 30/04/2024
Director TitleAgeSince
Chairman 62 05/11/2024
Director/Board Member 58 15/03/2018
Chairman 74 -
Date Insider Type Main position Quantity % Market Cap.
13/02/26 Buy

Founder

250 0.0001%
13/02/26 Buy

Chief Financial Officer

500 0.0001%
13/02/26 Buy

Founder

500 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.64%-63.45%-97.88% 15.45M
-0.36%-9.20%+14.18%-38.41% 15.54B
-7.90%+5.00%+0.62%+89.29% 1.65B
-3.20%-7.65%-39.04%-81.82% 1.09B
-1.41%-4.66%-38.14%+11.27% 948M
-3.39%-5.61%-34.57%-55.85% 609M
-2.46%-5.34%-49.25%-59.41% 505M
+1.87%+3.51%+44.64%-52.83% 460M
+1.52%-3.98%-57.01%-61.54% 365M
-4.04%-6.39%+49.24% - 315M
Average -1.94%-3.62%-17.28%-38.58% 2.15B
Weighted average by Cap. -1.24%-7.29%+5.16%-30.26%

Financials

2024 2025
Net sales 2.29 2.01 1.87 1.72 3.23 221.03 3.28 22.23 8.68 108.34 8.59 8.41 374.92 3 2.64 2.45 2.25 4.23 289.68 4.3 29.14 11.38 141.99 11.26 11.02 491.37
Net income -33.46M -29.44M -27.36M -25.12M -47.15M -3.23B -47.94M -325M -127M -1.58B -126M -123M -5.48B -20.4M -17.95M -16.68M -15.32M -28.75M -1.97B -29.23M -198M -77.37M -966M -76.58M -74.93M -3.34B
Net Debt 3.86M 3.39M 3.15M 2.89M 5.43M 372M 5.52M 37.44M 14.62M 182M 14.47M 14.16M 631M 4.6M 4.05M 3.76M 3.45M 6.48M 444M 6.59M 44.67M 17.45M 218M 17.27M 16.9M 753M
Logo Renalytix Plc
Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. KidneyIntelX, is a vitro diagnostic platform, employs a proprietary algorithm that combines diverse data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record or EHR, systems, to generate a patient risk score. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
Employees
46
Date Price Change Volume
24/07/26 GBX 2.650 0.00% 162,604
23/07/26 GBX 2.650 -1.85% 178,155
22/07/26 GBX 2.700 -1.82% 68,751
21/07/26 GBX 2.750 0.00% 103,728
20/07/26 GBX 2.750 0.00% 395,301

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RENX Stock